Sunday, 3 November 2013

Yahoo! Finance: Biotechnology Industry News: Will Seattle Genetics Stay Ahead of ImmunoGen and Celldex?

Yahoo! Finance: Biotechnology Industry News
The latest news on the Biotechnology industry from Yahoo! Finance 
The Next Generation in Online Meetings

GoTo Webinar is a new, affordable, do-it-yourself Web event service that doesn't require a consultant. Get $10 off after your complimentary trial.
From our sponsors
Will Seattle Genetics Stay Ahead of ImmunoGen and Celldex?
Nov 3rd 2013, 19:27

[at Motley Fool] - Seattle Genetics has had huge success in fighting cancer, but ImmunoGen and Celldex Therapeutics are aiming at the same market.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment